Renata Monteiro Lima

Renata Monteiro Lima

Auto-generated profile, based on publicly available information

Renata Monteiro Lima

UNIVERSIDADE FEDERAL DO MARANHÃO

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Revista Brasileira de Saúde Materno Infantil
Verified
Journal Article
Open access
PDF file
RLRenata Monteiro Lima
Renata Monteiro Lima
ELElisângela Veruska Nóbrega Crispim Leite
Elisângela Veruska Nóbrega Crispim Leite
DFDanielle França Furtado
Danielle França Furtado
ASAlcione Miranda dos Santos Santos
Alcione Miranda dos Santos Santos
Objectives: to describe the prevalence and factors associated with the consumption of folic acid and iron among puerperal women in the city of São Luís, Maranhão. Methods: a cross-sectional study with 4,036 puerperal women through a standardized questionnaire. The dependent variables (outcomes) were: the consumption of folic acid during pregnancy, iron and folic acid before pregnancy. The independent variables: age; schooling; skin color; marital status; income; planned pregnancy; place and number of prenatal consultations. Statistical analyzes were performed on STATA 14.0. For the first two outcomes, Poisson model with a robust variance was used. And for the last one, logistic regression. Results: the prevalence of consuming folic acid and iron during pregnancy were, respec-tively, 77.27% and 84.98%. However, only 0.37% reported the consume of folic acid and iron before pregnancy. In the adjusted analysis, the variables associated with the consumption of folic acid during pregnancy were: schooling and income; the consume of iron during preg-nancy, age only; and for those who consumed folic acid before pregnancy, no variable was statistically significant. Conclusions: high percentage of puerperal women who consumed folic acid and iron supplements during pregnancy, however, the recommended consumption of folic acid before pregnancy was low and maternal, social and economic factors influence the consumption of these supplements.

16 January 2022 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
RLRenata Monteiro Lima
Renata Monteiro Lima
JGJoseane Lima Prado Godinho
Joseane Lima Prado Godinho
EMElma Izze da Silva Magalhães
Elma Izze da Silva Magalhães
ABAnaximandro Braga Brito
Anaximandro Braga Brito
MBMaria Helena Seabra Soares de Britto
Maria Helena Seabra Soares de Britto
ASAlcione Miranda dos Santos Santos
Alcione Miranda dos Santos Santos
Objectives: To describe the medication profile used during pregnancy in a Brazilian capital. Methods: Descriptive cross-sectional study with data from BRISA study in São Luís, Maranhão. Participants were interviewed in hospitals and maternity hospitals after delivery and were asked about the use of medications during pregnancy. The drugs were classified according the Anatomical Therapeutic Chemical Classification and risk categories of the Food and Drug Administration. Results: 5,110 puerperal women were interviewed, of which 93.5% reported the use of at least one medication during pregnancy. The most frequent medications were: antianemic preparations (ferrous sulfate: 72.2%; iron and multivitamins: 4.9%, folic acid: 62.9% and associations with folic acid: 6.7%), vitamins (multivitamins and others minerals: 30.3%), analgesics (paracetamol: 12.3%), antibacterials for systemic use (cephalexin: 5.6%), antiemetics and anti-nauseating agents (scopolamine butylbromide: 5.4%) and antihypertensives (methyldopa): 3.6%). Among the drugs reported: 74.5% were from category A, 18.9% from category B, 5.5% from category C, 1.0% from category D and 0.1% from category X. Conclusions: Despite, the higher prevalence of medication use during pregnancy, most of which are considered safe in pregnancy. However, it is important that the use of drugs during pregnancy is monitored and guided by health professionals in order to ensure its rational use.